Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dalroi who wrote (1516)	5/14/2003 7:05:41 PM
From: Miljenko Zuanic	Read Replies (2) of 3044

Stefaan, <<perhaps we should start looking at fda postponed drugs like the one from prcs/sepr.>> There is no white and black contrast. Every NDA, every candidate is new story. FDA is getting seriously down to basic business and that is good for whole pharma industry. Velcade approval was clear cut. <<if velcade is now approived doesnt that put mlnm in a beter bargaining positon concerning partnership or is this going to be announced before the open tomorrow>> I think that partner should be pleased with Velcade initial label. More close to second line than third line MM therapy. Also, FDA requested comparing Velcade to standard therapy (not Dexa), so this should means that FDA is aware of moving V toward first line therapy. Miljenko PS: You can always buy calls back, as I did with my ABGX hedge after Iressa approval.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next